NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
Steba Biotech S.A.
Steba Biotech S.A.
Steba Biotech S.A.
Steba Biotech S.A.